BE900012A - Nouveau peptide. - Google Patents

Nouveau peptide.

Info

Publication number
BE900012A
BE900012A BE0/213217A BE213217A BE900012A BE 900012 A BE900012 A BE 900012A BE 0/213217 A BE0/213217 A BE 0/213217A BE 213217 A BE213217 A BE 213217A BE 900012 A BE900012 A BE 900012A
Authority
BE
Belgium
Prior art keywords
new peptide
calcitonins
medicaments
disorders
salts
Prior art date
Application number
BE0/213217A
Other languages
English (en)
Inventor
Jan A Prof Dr Fischer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of BE900012A publication Critical patent/BE900012A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne une substance du groupe des calcitonines et ses sels, que l'on peut isoler du corps humain ou obtenir d'une autre manière; procédé pour leur préparation, leur application comme médicaments et les préparations pharmaceutiques qui les contiennent, pour le traitement des désordres du métabolisme osseux.
BE0/213217A 1983-06-27 1984-06-26 Nouveau peptide. BE900012A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3496/83A CH657858A5 (de) 1983-06-27 1983-06-27 Substanz aus der gruppe der calcitonine.

Publications (1)

Publication Number Publication Date
BE900012A true BE900012A (fr) 1984-12-27

Family

ID=4257248

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213217A BE900012A (fr) 1983-06-27 1984-06-26 Nouveau peptide.

Country Status (16)

Country Link
US (1) US4845080A (fr)
JP (1) JPS6019721A (fr)
AU (1) AU578897B2 (fr)
BE (1) BE900012A (fr)
CH (1) CH657858A5 (fr)
DE (1) DE3423370A1 (fr)
DK (1) DK311884A (fr)
FR (1) FR2549070B1 (fr)
GB (1) GB2142335B (fr)
IL (1) IL72219A (fr)
IT (1) IT1199150B (fr)
LU (1) LU85422A1 (fr)
NL (1) NL8402017A (fr)
NZ (1) NZ208669A (fr)
SE (1) SE8403377L (fr)
ZA (1) ZA844857B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
US5010174A (en) * 1987-07-08 1991-04-23 Mitsubishi Petrochemical Co., Ltd. Novel calcitonin derivative and salt thereof
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
WO2001056594A1 (fr) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Formulations de calcitonine pour administration par voie nasale
ES2694812T3 (es) * 2013-06-04 2018-12-27 Basf Se Proceso para la reducción del carbono orgánico total en aguas residuales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555838B2 (en) * 1981-07-15 1986-10-09 Celltech Limited Human calcitonin precursor polyprotein structural gene
US5374618A (en) * 1983-06-15 1994-12-20 Celltech Limited Calcitonin peptides, and gene related pharmaceutical compositions

Also Published As

Publication number Publication date
CH657858A5 (de) 1986-09-30
NL8402017A (nl) 1985-01-16
IL72219A (en) 1988-07-31
FR2549070B1 (fr) 1988-02-05
AU2990784A (en) 1985-01-03
GB8415884D0 (en) 1984-07-25
DK311884D0 (da) 1984-06-26
SE8403377L (sv) 1984-12-28
LU85422A1 (de) 1985-03-26
IT8448461A0 (it) 1984-06-27
AU578897B2 (en) 1988-11-10
SE8403377D0 (sv) 1984-06-25
IL72219A0 (en) 1984-10-31
GB2142335A (en) 1985-01-16
ZA844857B (en) 1985-02-27
NZ208669A (en) 1988-06-30
IT1199150B (it) 1988-12-30
DK311884A (da) 1984-12-28
JPS6019721A (ja) 1985-01-31
GB2142335B (en) 1986-09-17
DE3423370A1 (de) 1985-01-17
FR2549070A1 (fr) 1985-01-18
US4845080A (en) 1989-07-04

Similar Documents

Publication Publication Date Title
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
DE3584120D1 (de) Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
IL65201A (en) Narang, saran a. wu, ray j. adaptor molecules for dna and their application to thesis of gene-derived products
FI904092A7 (fi) Lääkevalmisteita ankarien kiputilojen käsittelyyn ja menetelmä niiden valmistamiseksi
PT74512B (en) Heterocyclic carboxamides compositions containing such compounds processes for their preparation and methods of treatment therewith
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE17858T1 (de) Angiotropine aus leukozyten und entzuendeten geweben: eine neue klasse von natuerlichen chemotropischen und mitogenen proteinen fuer die spezifische induktion des gesteuerten wachstums von blutgefaessen, fuer neue gefaessbildung von geweben und fuer die morphogenese von blutgefaessverzweigungen; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen.
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
GR861803B (en) Novel carbonic acid derivatives method for their preparation their use and medicine containing them
PT84258A (en) Process for the preparation of cross-protective human monoclonal antibodies and of pharmaceutical compositions containing the same
EP0270690A4 (fr) Medicament pour le traitement et la prophylaxie de maladies du rein et du foie.
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
PT74927B (en) Method for the preparation of pharmaceutical compositions for the treatment of skin
CZ28395A3 (en) Therapeutic composition containing whey protein concentrate
FR2499407B1 (fr) Composition pharmaceutique et son application therapeutique pour le traitement des maladies de la cavite buccale
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
IL85776A (en) Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system
BE904846A (fr) Steroides 11beta-substitues utiles notamment dans le traitement des tumeurs hormono-dependantes et procede pour la fabrication.
BE902055A (fr) Preparations pharmaceutiques.
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CIBA-GEIGY A.G.

Effective date: 19920630